Cell culture market size to increase by USD 17.74 billion from 2022 to 2027; North America to contribute 39% of market growth - Technavio

NEW YORK, June 23, 2023 /PRNewswire/ -- The cell culture market size is expected to grow by USD 17.74 billion from 2022 to 2027, progressing at a CAGR of 11.3% as per the latest Technavio market research report. North America is estimated to account for 39% of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The cell culture market in the United States is growing rapidly, due to a number of factors. One major factor is the presence of large, well-funded companies such as Thermo Fisher Scientific, which are investing heavily in new manufacturing facilities. These facilities are equipped with the latest bioprocessing technology, making them ideal for cell culture. Another important factor driving the cell culture market is research on stem cells and cancer. As the number of cancer cases increases, there is a growing need for cell-based therapies and vaccines. Finally, the presence of sophisticated healthcare manufacturing facilities in the US is also a major factor contributing to market growth. These facilities provide the infrastructure and expertise necessary to produce high-quality cell culture products. Overall, the cell culture market in the United States is expected to continue to grow rapidly in the coming years. This growth is being driven by a number of factors, including the presence of large, well-funded companies, investment from other regions, research on stem cells and cancer, and the presence of sophisticated healthcare manufacturing facilities. This will increase the product offerings by the companies and their visibility in the region, which in turn will increase the demand for cell culture. For more insights on the market share of various regions- Download a sample report in MINUTES

What's New?

• Special coverage on the Russia-Ukraine war; global inflation; recovery analysis from COVID-19; supply chain disruptions, global trade tensions; and risk of recession 
• Global competitiveness and key competitor positions 
• Market presence across multiple geographical footprints - Strong/Active/Niche/Trivial - buy the report!

Cell Culture Market: Market Dynamics

Cell Culture Market: High growth potential from emerging regions notably drives growth

The high growth potential from emerging regions is notably driving the market growth. In developing regions, especially in countries such as India, China, and South Africa, cell culture technology has a high potential for growth. The cell culture market in emerging economies is growing rapidly, due to a number of factors. These economies have a rapidly developing infrastructure in the pharmaceutical and biotechnology industries, which supports cell culture and healthcare facilities. In addition, manufacturers are expanding their production facilities in these economies due to low labor and raw material costs, favorable government initiatives, and a large population. For example, Thermo Fisher Scientific is one company that is expanding its presence in emerging economies such as China, India, and the Middle East. The company is taking growth initiatives to increase its revenue from these regions. These initiatives are likely to increase awareness and adoption of advanced technologies such as cell culture in developing regions. This will lead to more vendors entering these markets, which will benefit the overall cell culture market. These factors will drive the global market growth during the forecast period. 

Cell Culture Market: Increasing Demand for Monoclonal Antibodies

The rising demand for monoclonal antibodies is an emerging trend in the market. Monoclonal antibodies are identical immune cells that are used in a wide range of applications, including biology, diagnostic imaging, medicine, and biochemistry. They are particularly effective in treating cancer, multiple sclerosis, rheumatoid arthritis, cardiovascular disease, and ulcerative colitis. With the rise of chronic diseases, the demand for monoclonal antibodies is increasing. Major manufacturers have built large production facilities to meet this demand. These facilities contain multiple cell culture bioreactors, which are used to grow and produce monoclonal antibodies. Thermo Fisher Scientific is one company that produces monoclonal antibodies. The company uses advanced cell culture platforms, single-use techniques, and a rapid test that detects viral or mycoplasma contamination. This ensures that the company produces high-quality, safe, and effective monoclonal antibodies. Thus, increasing demand for monoclonal antibodies is likely to increase the demand for cell culture consumables and equipment, which will positively impact the market growth.

To know about more drivers, trends along with challenges - Download a sample now!

Some of the key Cell Culture Market Players:

The cell culture market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market.

Agilent Technologies Inc., Avantor Inc., Becton Dickinson and Co., Bio Techne Corp., CLS Cell Lines Service GmbH, Corning Inc., Danaher Corp., Eppendorf AG, FUJIFILM Holdings Corp, General Electric Co., InvivoGen, LABGENE Scientific SA, Lonza Group Ltd., Merck KGaA, Miltenyi Biotec B.V. and Co. KG, PromoCell GmbH, Sartorius AG, Sartorius CellGenix GmbH, Thermo Fisher Scientific Inc., and ZenBio Inc.

Cell Culture Market: Segmentation Analysis

This report extensively covers market segmentation by product (consumables and equipment), end-user (pharma and biotech companies, hospitals, research and academic institutes, and others), and geography (North America, Europe, Asia, and the Rest of the World). It also includes an in-depth analysis of drivers, trends, and challenges. 

• The market share growth by the consumables segment will be significant during the forecast period. The consumables used in cell culture include sera, media, and reagents. The consumables segment is the largest revenue-generating segment in the global cell culture market. This is because consumables are widely available, have a wide range of applications, and can be used repeatedly. Additionally, consumables are relatively inexpensive, which makes them more affordable for businesses and research institutions. The rise in the number of diseases among the global population is also driving the growth of the consumables segment. As the demand for cell-based therapies and research increases, so does the demand for consumables. Vendors are responding to this demand by investing in research and development to develop new and improved cell media, reagents, and supplements. Therefore, because of the above-mentioned reasons, there will be a rise in this segment during the forecast period.

For additional information on the market contribution of each segment - Grab an Exclusive Sample Report

Gain instant access to 17,000+ market research reports

Technavio's SUBSCRIPTION platform

Related Reports:

he cell culture consumables market size is estimated to grow at a CAGR of 22.3% between 2022 and 2027. The size of the cell culture market is forecast to increase by USD 23,729.7 million. This market report extensively covers market segmentation by application (biopharmaceutical production, cancer research, and others) and geography (North America, Europe, Asia, and the Rest of the World). The growing demand for monoclonal antibodies is notably driving market growth. 

The 3D cell culture market share is expected to increase by USD 1.28 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 15.69%. This report extensively covers 3D cell culture market segmentation by application (cancer and stem cell research, drug discovery and toxicology testing, and tissue engineering and regenerative medicine) and geography (North America, Europe, Asia, and the Rest of World (ROW)). One of the key factors driving the global 3D cell culture market growth is the increase in infectious diseases.

Table of content 

1 Executive Summary

• 1.1 Market overview 
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem 
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition 
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022 

• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global cell culture market 2017 - 2021
• Exhibit 18: Historic Market Size – Data Table on Global cell culture market 2017 - 2021 ($ billion)

• 4.2 Product Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 ($ billion)

• 4.3 End-user Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size – End-user Segment 2017 - 2021 ($ billion)

• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ billion)

• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary 
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry 
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition 
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product

• 6.1 Market segments 
• Exhibit 30: Chart on Product - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Product - Market share 2022-2027 (%)

• 6.2 Comparison by Product 
• Exhibit 32: Chart on Comparison by Product
• Exhibit 33: Data Table on Comparison by Product

• 6.3 Consumables - Market size and forecast 2022-2027
• Exhibit 34: Chart on Consumables - Market size and forecast 2022-2027 ($ billion)
• Exhibit 35: Data Table on Consumables - Market size and forecast 2022-2027 ($ billion)
• Exhibit 36: Chart on Consumables - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Consumables - Year-over-year growth 2022-2027 (%)

• 6.4 Equipment - Market size and forecast 2022-2027
• Exhibit 38: Chart on Equipment - Market size and forecast 2022-2027 ($ billion)
• Exhibit 39: Data Table on Equipment - Market size and forecast 2022-2027 ($ billion)
• Exhibit 40: Chart on Equipment - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Equipment - Year-over-year growth 2022-2027 (%)

• 6.5 Market opportunity by Product 
• Exhibit 42: Market opportunity by Product ($ billion)

7 Market Segmentation by End-user

• 7.1 Market segments 
• Exhibit 43: Chart on End-user - Market share 2022-2027 (%)
• Exhibit 44: Data Table on End-user - Market share 2022-2027 (%)

• 7.2 Comparison by End-user 
• Exhibit 45: Chart on Comparison by End-user
• Exhibit 46: Data Table on Comparison by End-user

• 7.3 Pharma and biotech companies - Market size and forecast 2022-2027 
• Exhibit 47: Chart on Pharma and biotech companies - Market size and forecast 2022-2027 ($ billion)
• Exhibit 48: Data Table on Pharma and biotech companies - Market size and forecast 2022-2027 ($ billion)
• Exhibit 49: Chart on Pharma and biotech companies - Year-over-year growth 2022-2027 (%)
• Exhibit 50: Data Table on Pharma and biotech companies - Year-over-year growth 2022-2027 (%)

• 7.4 Hospitals - Market size and forecast 2022-2027
• Exhibit 51: Chart on Hospitals - Market size and forecast 2022-2027 ($ billion)
• Exhibit 52: Data Table on Hospitals - Market size and forecast 2022-2027 ($ billion)
• Exhibit 53: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
• Exhibit 54: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)

• 7.5 Research and academic Institutes - Market size and forecast 2022-2027 
• Exhibit 55: Chart on Research and academic Institutes - Market size and forecast 2022-2027 ($ billion)
• Exhibit 56: Data Table on Research and academic Institutes - Market size and forecast 2022-2027 ($ billion)
• Exhibit 57: Chart on Research and academic Institutes - Year-over-year growth 2022-2027 (%)
• Exhibit 58: Data Table on Research and academic Institutes - Year-over-year growth 2022-2027 (%)

• 7.6 Others - Market size and forecast 2022-2027
• Exhibit 59: Chart on Others - Market size and forecast 2022-2027 ($ billion)
• Exhibit 60: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
• Exhibit 61: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 62: Data Table on Others - Year-over-year growth 2022-2027 (%)

• 7.7 Market opportunity by End-user 
• Exhibit 63: Market opportunity by End-user ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 65: Chart on Market share by geography 2022-2027 (%)
• Exhibit 66: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 67: Chart on Geographic comparison
• Exhibit 68: Data Table on Geographic comparison

• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 69: Chart on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibit 70: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibit 71: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 72: Data Table on North America - Year-over-year growth 2022-2027 (%)

• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 73: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibit 74: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibit 75: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 76: Data Table on Europe - Year-over-year growth 2022-2027 (%)

• 9.5 Asia - Market size and forecast 2022-2027 
• Exhibit 77: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibit 78: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibit 79: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 80: Data Table on Asia - Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 
• Exhibit 81: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibit 82: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibit 83: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 84: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

• 9.7 US - Market size and forecast 2022-2027
• Exhibit 85: Chart on US - Market size and forecast 2022-2027 ($ billion)
• Exhibit 86: Data Table on US - Market size and forecast 2022-2027 ($ billion)
• Exhibit 87: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 88: Data Table on US - Year-over-year growth 2022-2027 (%)

• 9.8 China - Market size and forecast 2022-2027
• Exhibit 89: Chart on China - Market size and forecast 2022-2027 ($ billion)
• Exhibit 90: Data Table on China - Market size and forecast 2022-2027 ($ billion)
• Exhibit 91: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 92: Data Table on China - Year-over-year growth 2022-2027 (%)

• 9.9 Germany - Market size and forecast 2022-2027
• Exhibit 93: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibit 94: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibit 95: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 96: Data Table on Germany - Year-over-year growth 2022-2027 (%)

• 9.10 Japan - Market size and forecast 2022-2027
• Exhibit 97: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
• Exhibit 98: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
• Exhibit 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibit 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)

• 9.11 UK - Market size and forecast 2022-2027
• Exhibit 101: Chart on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibit 102: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibit 103: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 104: Data Table on UK - Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 105: Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers 

• 10.2 Market challenges 

• 10.3 Impact of drivers and challenges 
• Exhibit 106: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends 

11 Vendor Landscape

• 11.1 Overview 

• 11.2 Vendor landscape 
• Exhibit 107: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption 
• Exhibit 108: Overview on factors of disruption

• 11.4 Industry risks 
• Exhibit 109: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered 
• Exhibit 110: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 111: Matrix on vendor position and classification

• 12.3 Agilent Technologies Inc. 
• Exhibit 112: Agilent Technologies Inc. - Overview
• Exhibit 113: Agilent Technologies Inc. - Business segments
• Exhibit 114: Agilent Technologies Inc. - Key news
• Exhibit 115: Agilent Technologies Inc. - Key offerings
• Exhibit 116: Agilent Technologies Inc. - Segment focus

• 12.4 Becton Dickinson and Co. 
• Exhibit 117: Becton Dickinson and Co. - Overview
• Exhibit 118: Becton Dickinson and Co. - Business segments
• Exhibit 119: Becton Dickinson and Co. - Key news
• Exhibit 120: Becton Dickinson and Co. - Key offerings
• Exhibit 121: Becton Dickinson and Co. - Segment focus

• 12.5 Bio Techne Corp. 
• Exhibit 122: Bio Techne Corp. - Overview
• Exhibit 123: Bio Techne Corp. - Business segments
• Exhibit 124: Bio Techne Corp. - Key news
• Exhibit 125: Bio Techne Corp. - Key offerings
• Exhibit 126: Bio Techne Corp. - Segment focus

• 12.6 CLS Cell Lines Service GmbH 
• Exhibit 127: CLS Cell Lines Service GmbH - Overview
• Exhibit 128: CLS Cell Lines Service GmbH - Product / Service
• Exhibit 129: CLS Cell Lines Service GmbH - Key offerings

• 12.7 Corning Inc. 
• Exhibit 130: Corning Inc. - Overview
• Exhibit 131: Corning Inc. - Business segments
• Exhibit 132: Corning Inc. - Key news
• Exhibit 133: Corning Inc. - Key offerings
• Exhibit 134: Corning Inc. - Segment focus

• 12.8 Danaher Corp. 
• Exhibit 135: Danaher Corp. - Overview
• Exhibit 136: Danaher Corp. - Business segments
• Exhibit 137: Danaher Corp. - Key news
• Exhibit 138: Danaher Corp. - Key offerings
• Exhibit 139: Danaher Corp. - Segment focus

• 12.9 Eppendorf AG 
• Exhibit 140: Eppendorf AG - Overview
• Exhibit 141: Eppendorf AG - Product / Service
• Exhibit 142: Eppendorf AG - Key news
• Exhibit 143: Eppendorf AG - Key offerings

• 12.10 FUJIFILM Holdings Corp 
• Exhibit 144: FUJIFILM Holdings Corp - Overview
• Exhibit 145: FUJIFILM Holdings Corp - Business segments
• Exhibit 146: FUJIFILM Holdings Corp - Key offerings
• Exhibit 147: FUJIFILM Holdings Corp - Segment focus

• 12.11 General Electric Co. 
• Exhibit 148: General Electric Co. - Overview
• Exhibit 149: General Electric Co. - Business segments
• Exhibit 150: General Electric Co. - Key news
• Exhibit 151: General Electric Co. - Key offerings
• Exhibit 152: General Electric Co. - Segment focus

• 12.12 InvivoGen 
• Exhibit 153: InvivoGen - Overview
• Exhibit 154: InvivoGen - Product / Service
• Exhibit 155: InvivoGen - Key offerings

• 12.13 LABGENE Scientific SA 
• Exhibit 156: LABGENE Scientific SA - Overview
• Exhibit 157: LABGENE Scientific SA - Product / Service
• Exhibit 158: LABGENE Scientific SA - Key offerings

• 12.14 Lonza Group Ltd. 
• Exhibit 159: Lonza Group Ltd. - Overview
• Exhibit 160: Lonza Group Ltd. - Business segments
• Exhibit 161: Lonza Group Ltd. - Key news
• Exhibit 162: Lonza Group Ltd. - Key offerings
• Exhibit 163: Lonza Group Ltd. - Segment focus

• 12.15 Merck KGaA 
• Exhibit 164: Merck KGaA - Overview
• Exhibit 165: Merck KGaA - Business segments
• Exhibit 166: Merck KGaA - Key news
• Exhibit 167: Merck KGaA - Key offerings
• Exhibit 168: Merck KGaA - Segment focus

• 12.16 Sartorius CellGenix GmbH 
• Exhibit 169: Sartorius CellGenix GmbH - Overview
• Exhibit 170: Sartorius CellGenix GmbH - Product / Service
• Exhibit 171: Sartorius CellGenix GmbH - Key news
• Exhibit 172: Sartorius CellGenix GmbH - Key offerings

• 12.17 Thermo Fisher Scientific Inc. 
• Exhibit 173: Thermo Fisher Scientific Inc. - Overview
• Exhibit 174: Thermo Fisher Scientific Inc. - Business segments
• Exhibit 175: Thermo Fisher Scientific Inc. - Key news
• Exhibit 176: Thermo Fisher Scientific Inc. - Key offerings
• Exhibit 177: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report 

• 13.2 Inclusions and exclusions checklist
• Exhibit 178: Inclusions checklist
• Exhibit 179: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 180: Currency conversion rates for US$

• 13.4 Research methodology 
• Exhibit 181: Research methodology
• Exhibit 182: Validation techniques employed for market sizing
• Exhibit 183: Information sources

• 13.5 List of abbreviations 
• Exhibit 184: List of abbreviations

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com

SOURCE Technavio